HomeMREO • NASDAQ
add
Mereo BioPharma Group plc - ADR
Previous close
$3.67
Day range
$3.57 - $3.86
Year range
$1.07 - $4.50
Market cap
588.28M USD
Avg Volume
1.39M
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.42M | -16.30% |
Net income | -8.95M | 25.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -9.27M | 14.17% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 48.66M | -28.63% |
Total assets | 55.94M | — |
Total liabilities | 13.10M | — |
Total equity | 42.84M | — |
Shares outstanding | 140.03M | — |
Price to book | 11.84 | — |
Return on assets | -38.48% | — |
Return on capital | -44.72% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -8.95M | 25.88% |
Cash from operations | -7.99M | 13.59% |
Cash from investing | -700.00K | -67.06% |
Cash from financing | — | — |
Net change in cash | -8.76M | -4.62% |
Free cash flow | -6.08M | — |
About
Founded
2015
Website
Employees
33